[KoNECT] 해외 임상시험 정보 데이터(GlobalData) 보고서

구분	보고서 (영문)
제약/바이오/임상시험	Bladder Cancer-Focused CG Oncology Files for IPO
	At Least Three Oncology 2023 Brand Launches Have Blockbuster Potential
	Contract Manufacturing: Opportunities and Threats – January 2024
	Bio/Pharmaceutical Outsourcing Report, January 2024
	Contract Service Agreements – January 2024
	January Quarterly Contract Manufacturing Mergers, Acquisitions, and Financing – Q1 2024
	Gilead’s Trodelvy Falters as Next Major ADC in Phase III NSCLC Trial
	Moderna Leads the Development of mRNA Vaccines in Infectious Diseases
	Cell and Gene Therapies – Top Pharmaceutical Industry Trend to Watch for 2024
	FDA Awarded Record Number of Review Designations to CRISPR Drugs in 2023
질환별	Follow-Up Analysis Reinforces Opdivo’s Use in PD-L1 Urothelial Carcinoma Patients
	Substance Use Disorder Linked with Increased Cardiac Mortality
	Increased Global Deaths from Fungal Disease Highlights Disease Management Obstacles
	Enlarged Prostate Decreases Quality of Life in Men
	2024 Kicks Off with a Surge in Clinical Trials Tackling Women’s Infertility
	Could MicroRNAs Offer a New Approach to the Diagnosis of Lupus Nephritis in Systemic Lupus Erythematosus?
	The US Dominates Ongoing/Planned Trials Researching Skin Cancer
컨퍼런스/심포지엄/학회/기타	Merck Is on the Lookout for More Opportunities Within Immunology
	AstraZeneca Posts Positive Preliminary Results for Imfinzi in TACE-Eligible Hepatocellular Carcinoma
	Germany’s Ministry of Health Refutes Accusations of Worsening Market Conditions